In particular, many of the well-characterized oncogenes, including PIK3CA, AKT, c-MYC and RAS, have been shown to promote glycolytic pathways, while tumour suppressors tend to inhibit glycolysis.1, 2 The RAS genes were the first oncogenes identified and are the most frequently mutated proteins in human cancers. Here, MYC is linked to cancer.